HONG KONG, Mar 7, 2016 - (ACN Newswire) - China Everbright Limited ("CEL", stock code: 165.HK)'s Catalyst CEL Fund (the "Fund") is pleased to announce an investment into a disruptive 3D printing company XJet Ltd. ("XJet" or …
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 shares of common …
Present at the listing ceremony were Chen Shuang, Executive Director and CEO of China Everbright Limited ("CEL"; …
WASHINGTON — Vienna, Virginia-based biotechnology company Cel-Sci, currently running late-stage clinical trials with patients for its head and neck cancer treatment, watched its stock fall more than 30 percent in early Tuesday trading …
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. CEL-SCI Corporation (NYSE: CVM) announced it has entered into a definitive agreement with institutional …
Cel-Sci - entered definitive agreement with one institutional investor for offering of shares of stock with proceeds of about $1.51 million in direct offering * Cel-Sci corp- intends to use net proceeds from offering for phase 3 clinical study and …
L.P. ("Fund"), a private equity fund sponsored and managed by China Everbright Limited ("CEL", stock code: 165.HK), was established and completed its first closing in the second quarter of 2016 with a total capital commitment of …
HONG KONG, Oct 7, 2016 - (ACN Newswire) - China Everbright Limited ("CEL", stock code: 165.HK) is pleased to announce that it has completed the acquisition of 100% shares in Tirana International Airport SHPK ("TIA"), after having …
HONG KONG, May 6, 2016 - (ACN Newswire) - Everbright (Qingdao) Investment Company Limited ("Everbright Qingdao …